Table 4.

Adverse Events and Discontinuations

Event a	Sofosbuvir-Ribavirin for 12 Weeks (N = 17)
≧Grade 2 AEs, n (%)	8 (47)
Grade 3‒4 AE, n (%)	1 (6)
Serious AE, n (%)	0
Treatment discontinuation due to AE, n (%)	0
Death, n (%)	0
Grade 3‒4 laboratory abnormality, n (%)	0

Abbreviation: AE, adverse event.

^aGrade 2 AE, insomnia, herpes lesion, fever with congestion, fatigue. Grade 3 AE, left big toe pain (not related). Grade 2 laboratory AE, elevated total bilirubin ×2, elevated fasting blood glucose, low phosphate, elevated fasting total cholesterol.